C125H156F3N27O15 — CID 167621719
1-[2-amino-5-(2,5-dimethylpyrrolidin-1-yl)-5-oxopentanoyl]-4-[(4-methoxyphenyl)methyl]-N-[(1-methylbenzotriazol-5-yl)methyl]pyrrolidine-2-carboxamide;1-(2-amino-5-oxo-5-pyrrolidin-1-ylpentanoyl)-4-[(4-methoxyphenyl)methyl]-N-[(1-methylimidazo[4,5-c]pyridin-2-yl)methyl]pyrrolidine-2-carboxamide;1-(2-amino-5-oxo-5-pyrrolidin-1-ylpentanoyl)-4-[(4-methoxyphenyl)methyl]-N-[(3-methylimidazo[4,5-c]pyridin-2-yl)methyl]pyrrolidine-2-carboxamide;4-[(4-methoxyphenyl)methyl]-N-[(1-methylbenzotriazol-5-yl)methyl]-1-[4-[2-(trifluoromethyl)phenyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxamide (PubChem CID 167621719) has the molecular formula C125H156F3N27O15 and a molecular weight of 2333.79 g/mol. Its IUPAC name is 1-[2-amino-5-(2,5-dimethylpyrrolidin-1-yl)-5-oxopentanoyl]-4-[(4-methoxyphenyl)methyl]-N-[(1-methylbenzotriazol-5-yl)methyl]pyrrolidine-2-carboxamide;1-(2-amino-5-oxo-5-pyrrolidin-1-ylpentanoyl)-4-[(4-methoxyphenyl)methyl]-N-[(1-methylimidazo[4,5-c]pyridin-2-yl)methyl]pyrrolidine-2-carboxamide;1-(2-amino-5-oxo-5-pyrrolidin-1-ylpentanoyl)-4-[(4-methoxyphenyl)methyl]-N-[(3-methylimidazo[4,5-c]pyridin-2-yl)methyl]pyrrolidine-2-carboxamide;4-[(4-methoxyphenyl)methyl]-N-[(1-methylbenzotriazol-5-yl)methyl]-1-[4-[2-(trifluoromethyl)phenyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxamide.
| Compound Name | 1-[2-amino-5-(2,5-dimethylpyrrolidin-1-yl)-5-oxopentanoyl]-4-[(4-methoxyphenyl)methyl]-N-[(1-methylbenzotriazol-5-yl)methyl]pyrrolidine-2-carboxamide;1-(2-amino-5-oxo-5-pyrrolidin-1-ylpentanoyl)-4-[(4-methoxyphenyl)methyl]-N-[(1-methylimidazo[4,5-c]pyridin-2-yl)methyl]pyrrolidine-2-carboxamide;1-(2-amino-5-oxo-5-pyrrolidin-1-ylpentanoyl)-4-[(4-methoxyphenyl)methyl]-N-[(3-methylimidazo[4,5-c]pyridin-2-yl)methyl]pyrrolidine-2-carboxamide;4-[(4-methoxyphenyl)methyl]-N-[(1-methylbenzotriazol-5-yl)methyl]-1-[4-[2-(trifluoromethyl)phenyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxamide |
|---|---|
| PubChem CID | 167621719 |
| Molecular Formula | C125H156F3N27O15 |
| Molecular Weight | 2333.79 g/mol |
| Exact Mass | 2332.22 |
| IUPAC Name | 1-[2-amino-5-(2,5-dimethylpyrrolidin-1-yl)-5-oxopentanoyl]-4-[(4-methoxyphenyl)methyl]-N-[(1-methylbenzotriazol-5-yl)methyl]pyrrolidine-2-carboxamide;1-(2-amino-5-oxo-5-pyrrolidin-1-ylpentanoyl)-4-[(4-methoxyphenyl)methyl]-N-[(1-methylimidazo[4,5-c]pyridin-2-yl)methyl]pyrrolidine-2-carboxamide;1-(2-amino-5-oxo-5-pyrrolidin-1-ylpentanoyl)-4-[(4-methoxyphenyl)methyl]-N-[(3-methylimidazo[4,5-c]pyridin-2-yl)methyl]pyrrolidine-2-carboxamide;4-[(4-methoxyphenyl)methyl]-N-[(1-methylbenzotriazol-5-yl)methyl]-1-[4-[2-(trifluoromethyl)phenyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carboxamide |
| SMILES | COc1ccc(CC2CC(C(=O)NCc3ccc4c(c3)nnn4C)N(C(=O)C(N)CCC(=O)N3C(C)CCC3C)C2)cc1.COc1ccc(CC2CC(C(=O)NCc3ccc4c(c3)nnn4C)N(C(=O)C3CC(c4ccccc4C(F)(F)F)CN3)C2)cc1.COc1ccc(CC2CC(C(=O)NCc3nc4ccncc4n3C)N(C(=O)C(N)CCC(=O)N3CCCC3)C2)cc1.COc1ccc(CC2CC(C(=O)NCc3nc4cnccc4n3C)N(C(=O)C(N)CCC(=O)N3CCCC3)C2)cc1 |
| InChI | InChI=1S/C33H35F3N6O3.C32H43N7O4.2C30H39N7O4/c1-41-29-12-9-21(14-27(29)39-40-41)17-38-31(43)30-15-22(13-20-7-10-24(45-2)11-8-20)19-42(30)32(44)28-16-23(18-37-28)25-5-3-4-6-26(25)33(34,35)36;1-20-5-6-21(2)39(20)30(40)14-12-26(33)32(42)38-19-24(15-22-7-10-25(43-4)11-8-22)17-29(38)31(41)34-18-23-9-13-28-27(16-23)35-36-37(28)3;1-35-25-11-12-32-17-24(25)34-27(35)18-33-29(39)26-16-21(15-20-5-7-22(41-2)8-6-20)19-37(26)30(40)23(31)9-10-28(38)36-13-3-4-14-36;1-35-26-17-32-12-11-24(26)34-27(35)18-33-29(39)25-16-21(15-20-5-7-22(41-2)8-6-20)19-37(25)30(40)23(31)9-10-28(38)36-13-3-4-14-36/h3-12,14,22-23,28,30,37H,13,15-19H2,1-2H3,(H,38,43);7-11,13,16,20-21,24,26,29H,5-6,12,14-15,17-19,33H2,1-4H3,(H,34,41);5-8,11-12,17,21,23,26H,3-4,9-10,13-16,18-19,31H2,1-2H3,(H,33,39);5-8,11-12,17,21,23,25H,3-4,9-10,13-16,18-19,31H2,1-2H3,(H,33,39) |
| InChIKey | MNONUCRZMZMFJP-UHFFFAOYSA-N |
| XLogP | 10.34 |
| TPSA | 508.42 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 38 |
| Heavy Atoms | 170 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2333.79 |
| LogP ≤ 5 | 10.34 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 31 |